Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
|Podcasts|December 30, 2018
Podcast: This Week in Managed Care—Recapping the Year in Managed Care
This week, The American Journal of Managed Care® recaps the top managed care news of the year, and you can now listen to it on our podcast, Managed Care Cast.
Advertisement
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, we recapped the top news from 2018 with a look at policy changes, new research, decisions at the polls, and more.
You may need to log in to the website to access this podcast.
iTunes:
TuneIn:
Stitcher:
Listen above or through one of these podcast services:
Read more about the stories in this podcast:
Advertisement
Related to this article
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
OCT patterns help distinguish MS, NMOSD, and MOGAD after optic neuritis, while timing and protocol shape MRI's diagnostic yield, experts say.
Among people with HIV, lung cancer screening eligibility rose from 6% to 15% in 6 years, but uptake stayed under 30%.
Invivyd's VYD2311 shows superior safety and tolerability vs Comirnaty in the phase 3 LIBERTY trial, with no vaccine interference.
Advertisement
Advertisement
Trending on AJMC
1
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
2
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
3
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5